Viral clearance

You have access
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration
John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina, David Roush, Scott Tobler, Bradford Stanley, Mike Clark, Justin Weaver, Jeremy Pike, Deqiang Yu, Xinfang Li, Andreas Flicker, Johanna Kindermann, Norbert Schuelke, Richard Whitcombe and Louise Bennett

PDA Journal of Pharmaceutical Science and Technology September 2019, 73 (5) 470-486; DOI: https://doi.org/10.5731/pdajpst.2018.009605
You have access
PDA Biosimilars Workshop Report (September 27—28, 2018)—Getting It Right the First Time for Biosimilar Marketing Applications
Stephan Krause, Emanuela Lacana, Joel Welch, Marjorie Shapiro, Christopher Downey, Jee Chung, Qing Zhou, Martijn Van Der Plas, Chantal Depatie, Bev Ingram, Catherine Srebalus-Barnes, Alla Polozova, Barbara Rellahan, Daeseok Choi, Richard Burdick, Thomas Stangler and Emily Shacter

PDA Journal of Pharmaceutical Science and Technology July 2019, 73 (4) 401-416; DOI: https://doi.org/10.5731/pdajpst.2019.010215
You have access
Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing
Paul W. Barone, Stephen Avgerinos, Rob Ballard, Audrey Brussel, Philip Clark, Chris Dowd, Lionel Gerentes, Ian Hart, Flora J. Keumurian, Johanna Kindermann, James C. Leung, Nguyen Ly, Sheldon Mink, Stefan Minning, Jürgen Mullberg, Marie Murphy, Kerstin Nöske, Sandi Parriott, Bonnie Shum, Michael E. Wiebe and Stacy L. Springs

PDA Journal of Pharmaceutical Science and Technology March 2019, 73 (2) 191-203; DOI: https://doi.org/10.5731/pdajpst.2018.008862
You have access
Proceedings of the 2017 Viral Clearance Symposium—
Stefan Hepbildikler and Franz Nothelfer

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 453-454; DOI: https://doi.org/10.5731/pdajpst.2018.009076
You have access
Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations–Purification Unit Operations
David Roush and Thomas R. Kreil

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 479-487; DOI: https://doi.org/10.5731/pdajpst.2018.009126
You have access
Proceedings of the 2017 Viral Clearance Symposium, Session 3: Resin Lifetime
Johannes Blümel and Junfen Ma

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 488-497; DOI: https://doi.org/10.5731/pdajpst.2018.009134
You have access
Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies
Astrid Schwantes, Rachel Specht and Qi Chen

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 498-510; DOI: https://doi.org/10.5731/pdajpst.2018.009142
You have access
Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing
Sarah A. Johnson and David Roush

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 516-524; DOI: https://doi.org/10.5731/pdajpst.2018.009183
You have access
Proceedings of the 2017 Viral Clearance Symposium: Conclusion
Stefan Hepbildikler, Sarah Johnson and Johannes Bluemel

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 525-530; DOI: https://doi.org/10.5731/pdajpst.2018.009084
You have access
Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies
Eva Gefroh, Houman Dehghani, Megan McClure, Lisa Connell-Crowley and Ganesh Vedantham

PDA Journal of Pharmaceutical Science and Technology May 2014, 68 (3) 297-311; DOI: https://doi.org/10.5731/pdajpst.2014.00978

Main menu

User menu

Search

Viral clearance

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.